TABLE 3.

Comparison of ophthalmologic examination between EAHE and placebo groups.

	EAHE group (n = 20)		Placebo group (n = 21)
Variables	Value	Intragroup p-value	Value	Intragroup p-value	Intergroup p-value
BCVA OD
Baseline	0.83 ± 0.24	–	0.59 ± 0.33	–	0.013*
Week 25	0.8 ± 0.27	0.552	0.59 ± 0.33	0.814	0.026*
Week 49	0.83 ± 0.2	0.545	0.57 ± 0.28	0.258	0.005*
BCVA OS
Baseline	0.82 ± 0.25	–	0.63 ± 0.27	–	0.024*
Week 25	0.77 ± 0.27	0.153	0.67 ± 0.23	0.633	0.101
Week 49	0.82 ± 0.24	0.824	0.64 ± 0.23	0.201	0.025*
BCVA OU
Baseline	0.9 ± 0.22	–	0.75 ± 0.23	–	0.017*
Week 25	0.89 ± 0.26	0.923	0.74 ± 0.21	0.472	0.027*
Week 49	0.88 ± 0.22	0.948	0.69 ± 0.2	0.104	0.005*
CS OD
Baseline	0.84 ± 0.19	–	0.72 ± 0.32	–	0.249
Week 25	0.86 ± 0.19	0.257	0.75 ± 0.29	0.187	0.212
Week 49	0.9 ± 0.08	0.257	0.77 ± 0.27	0.582	0.089
CS OS
Baseline	0.83 ± 0.2	–	0.83 ± 0.18	–	0.323
Week 25	0.82 ± 0.25	0.85	0.82 ± 0.11	0.227	0.155
Week 49	0.86 ± 0.13	0.606	0.78 ± 0.17	0.13	0.046*
CS OU
Baseline	0.88 ± 0.15	–	0.85 ± 0.19	–	0.28
Week 25	0.88 ± 0.2	0.739	0.86 ± 0.09	0.405	0.069
Week 49	0.89 ± 0.11	0.68	0.85 ± 0.08	0.033*	0.056

Values are given as mean ± SD. BCVA = best-corrected visual acuity; CS = contrast sensitivity; OD = oculus dexter; OS = oculus sinister; OU = oculus uterque. ^∗p < 0.05.